GlassScriptPhysician profile
Dharmesh P Bhakta
NPI 1346243243
$105,024.36
in general payments reported to CMS, 2019-2025
34 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,565 · 2020: $219 · 2021: $201 · 2022: $435 · 2023: $58K · 2024: $42K · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $96K · Food and Beverage: $2,837 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,000 · Consulting Fee: $500 · Education: $17.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $96,250.00 |
| Food and Beverage | $2,836.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,000.00 |
| Consulting Fee | $500.00 |
| Education | $17.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $96,250.00 | 2023-2024 | Fuse Ultra Foot Plating System, Fuse Ultra Foot Plating System |
| Biogennix, LLC | $2,213.16 | 2023-2024 | Agilon, Agilon Surgical Matrix |
| Melinta Therapeutics, LLC | $2,025.30 | 2019 | |
| Stryker Corporation | $1,038.86 | 2021-2025 | Augment Injectable, Infinity Adaptis, Prostep Mica |
| Medical Device Business Services, INC. | $935.89 | 2019 | |
| Bone Support INC. | $758.92 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Integra Lifesciences Corporation | $499.86 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Wright Medical Technology, INC. | $272.89 | 2019-2020 | |
| Medtronic Vascular, INC. | $116.59 | 2019 | |
| Horizon Therapeutics Plc | $93.73 | 2019-2021 | |
| Reprise Biomedical, INC. | $70.97 | 2023-2024 | Miro3d |
| Nevro Corp. | $66.06 | 2019-2023 | Senza |
| Linvatec Corporation | $59.04 | 2020 | |
| Smith+Nephew, INC. | $56.33 | 2019 | |
| Zyla Life Sciences, INC. | $55.48 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $54.83 | 2020-2025 | Exparel |
| Abbott Laboratories | $51.43 | 2019-2022 | |
| Bioventus LLC | $50.57 | 2025 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $44.73 | 2025 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.04 | 2023-2025 | Jublia, Cabtreo |
| Misonix INC | $33.46 | 2020 | |
| Paratek Pharmaceuticals, INC. | $29.97 | 2019-2021 | |
| Cpm Medical Consultants, LLC | $28.79 | 2025 | |
| Depuy Synthes Sales INC. | $23.82 | 2019 | |
| Ibsa Pharma INC. | $22.67 | 2024 | Tirosint, Licart |
| Organogenesis INC. | $21.02 | 2021 | |
| Heron Therapeutics, INC. | $20.28 | 2021 | |
| Maruho Medical, INC. | $17.86 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.89 | 2023 | Seglentis |
| Polynovo North America LLC | $14.58 | 2025 | Novosorb Btm |
| Baudax Bio INC. | $14.54 | 2021 | |
| Merck Sharp & Dohme LLC | $12.08 | 2019 | |
| Tactile Systems Technology INC | $11.80 | 2019 | |
| Orthofix Medical, INC. | $9.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dharmesh Bhakta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.